ESMO 2022 | Facilitating the decision making process in healthcare research

Matthew Gitlin, PharmD, BluePath Solutions, Los Angeles, CA, describes the role of BluePath Solutions in the field of healthcare research. Collaborating with industry partners to evaluate the value to technology used in clinical settings have enabled improved evidence-based decision making as well as identifying unmet needs. The research current conduced will additionally hope to increase similar efforts in other institutions. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.